CRISPR Therapeutics AG (CRSP) is a publicly traded Healthcare sector company. As of May 20, 2026, CRSP trades at $48.90 with a market cap of $4.68B and a P/E ratio of -7.51. CRSP moved +2.03% today. Year to date, CRSP is -11.49%; over the trailing twelve months it is +23.04%. Its 52-week range spans $30.04 to $78.48. Analyst consensus is buy with an average price target of $75.00. Rallies surfaces CRSP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CRISPR Therapeutics AG (CRSP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CRSP moved +2.03% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $48.90 |
| Market Cap | $4.68B |
| P/E Ratio | -7.51 |
| EPS | $-6.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $78.48 |
| 52-Week Low | $30.04 |
| Volume | 1.52M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.51M |
| Net Income | $-581.60M |
| Gross Margin | 0.00% |
14 analysts cover CRSP: 0 strong buy, 10 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $75.00.